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Summary 
CRMP2-binding compound, edonerpic maleate accelerates  
motor function recovery from brain injury 
CRMP2 に結合する低分⼦化合物 edonerpic maleate の脳損傷後運動機能回復促進作⽤ 
http://science.sciencemag.org/content/360/6384/50/tab-pdf 
Background 
Pharmacological intervention to enhance rehabilitation from stroke have been investigated in animal 
models and clinical trials with focuses on neuro modulatory pathways. While certain small-scale 
studies have suggested that dextroamphetamine, L-3,4-dihydroxyphenylalanine, and selective 
serotonin uptake inhibitors enhance motor function recovery, larger studies such as randomized 
controlled trials have failed to reveal a promoting effect. Thus, the concept of pharmacological 
enhancement for stroke rehabilitation needs to be reconsidered. Here, we propose a concept that it 
could be a rehabilitation-accelerating strategy to modulate the glutamate receptors trafficking to post 
synaptic membrane in non-injured lesions after brain damage.  
Materials and Methods / Results  
Based on the concept described above, we aimed to develop a rehabilitation accelerating agent to 
facilitate AMPA (a-amino-3-hydroxy-5-methyl-4-isoxazole-propionic-acid) receptors trafficking to 
the post synaptic membrane. To identify a small compound which could enhance AMPA receptors 
trafficking, we focused on layer 4/2-3 pyramidal synapses in the mice barrel cortex (a sensory cortex 
responsible for sensory inputs from whiskers), where the sensory experience - dependent AMPA 
receptor trafficking occurs in the neonate but not in the adult. After administering each compound, 
electrophysiological response was evaluated in synapses within the layers 4/2-3 of the adult mice 
barrel cortex. Using this screening strategy in vivo, we found that edonerpic maleate has the potential 
to enhance AMPA receptors trafficking even in the adult mice barrel cortex. Interestingly, we also 
found that edonerpic maleate facilitates synaptic AMPA receptor trafficking only in the presence of 
whiskers. Then, we tried to identify the target molecule of edonerpic maleate using mass spectroscopy 
and found that it binds to collapsin response mediator protein 2 (CRMP2). We also found that 
edonerpic maleate -CRMP2 complex activates actin depolarizing factor (ADF)/cofilin in a plasticity 
inducing condition.       
The effect of edonerpic maleate on the motor function recovery was first examined in rodents. After 
the mice successfully learned the reaching forelimb task, we introduced a cryoinjury in their motor 
cortex. For at least 3 weeks, these mice persistently failed in the performance of reaching task that 
evaluates forelimb reaching. We examined the efficacy of edonerpic maleate in these mice. Mice 
administered with edonerpic maleate (30 mg/kg, twice a day) during rehabilitative training for 3 weeks 
following the introduction of cryoinjury showed a marked recovery compared to control mice. 
Interestingly, mice administered with edonerpic maleate (30 mg/kg, twice a day) without rehabilitative 
training showed no recovery. These results suggested that edonerpic maleate promotes motor function 
recovery after brain damage in a training - dependent manner. We also confirmed the same efficacy of 
the compound at the dose which was proven to be safe in human clinical trial. We next evaluated the 
effect of edonerpic maleate in non-human primate model. To evaluate the efficacy of edonerpic 
maleate in non-human primates, we introduced an internal capsule hemorrhage (ICH) by a focal 
stereotaxic injection of collagenase. Following this induction, the animal showed severe disabilities in 
forelimb reaching and manual dexterity. Subsequently, we evaluated the forelimb function and manual 
dexterity in non-human primates treated with edonerpic maleate in combination with rehabilitation. 
We observed the robust effect of edonerpic maleate on motor function recovery after ICH. We 
therefore demonstrated remarkable effects of edonerpic maleate on motor function recovery not only 
in rodents but also in non-human primates.  
 
Discussion  
The efficacy of edonerpic maleate in stroke should be tested in clinical trials at the earliest. To further 
screen a more effective compound, pharmacological and biological mechanism of edonerpic maleate 
such as signaling pathway to facilitate synaptic AMPA receptor delivery should be studied. Recently, 
the constrained induced therapy, robotics, and repetitive transcranial magnetic stimulation has been 
introduced at the clinical site. Thus, combinatorial approaches of these technologies with 
pharmacological intervention with edonerpic maleate could maximize the potential of our medical 
options for the treatment of brain damage such as stroke. 
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